What is the recommended management of myocardial bridging in a patient with hypertrophic obstructive cardiomyopathy?

Management of Myocardial Bridging in HOCM

Myocardial bridging (MB) in patients with hypertrophic obstructive cardiomyopathy (HOCM) should be surgically unroofed at the time of septal myectomy when identified, as MB is associated with myocardial ischemia and can contribute to persistent anginal symptoms even after successful gradient relief.

Initial Medical Management

The presence of MB does not fundamentally alter the first-line medical approach to HOCM. Start with non-vasodilating beta-blockers as first-line therapy, which serve dual purposes: reducing left ventricular outflow tract (LVOT) obstruction and potentially improving coronary flow dynamics through the bridged segment 1. One case report demonstrated reversal of apical hypokinesis associated with severe MB following beta-blocker initiation 2.

Key medical management principles:

• Titrate beta-blockers to achieve physiologic beta-blockade (suppressed resting heart rate), not just to a standard dose 1
• Avoid vasodilators (ACE inhibitors, ARBs, dihydropyridine calcium channel blockers) as these worsen LVOT obstruction 1
• Verapamil or diltiazem are reasonable alternatives to beta-blockers, though verapamil is potentially harmful in patients with very high resting gradients (>100 mm Hg) 1

Diagnostic Evaluation of MB Significance

MB is notably common in HCM, occurring in approximately 21% of pediatric cases 3. The hemodynamic significance of MB correlates with compression ratio: patients with MB compression ratio >65% typically require surgical intervention 4.

Critical assessment points:

• Perform provocative angiographic testing to confirm ischemia secondary to MB 5
• MB is associated with myocardial ischemia (OR 1.89, p=0.04) but not independently with cardiovascular mortality 6
• Consider cardiac MRI for tissue characterization and ischemia assessment 7

Surgical Decision-Making Algorithm

For symptomatic HOCM patients undergoing septal myectomy who have identified MB, surgical unroofing should be performed concomitantly 5, 3. This is particularly important because:

1. MB can cause persistent angina despite successful gradient relief from myectomy alone 5
2. The surgical approach (transaortic extended septal myectomy) allows simultaneous correction of both pathologies 1
3. Pediatric data shows MB is present in 21.4% of children undergoing myectomy, supporting routine evaluation 3

Specific Indications for Surgical Unroofing:

Proceed with unroofing when:

• MB compression ratio >65% on hemodynamic assessment 4
• Provocative testing confirms significant ischemia 5
• Patient has refractory anginal symptoms despite optimal medical therapy
• Patient is already undergoing septal myectomy for LVOT obstruction 1

Surgical myectomy is recommended over alcohol septal ablation when MB is present, as it allows direct surgical correction of both the septal hypertrophy and MB 1. The procedure can be performed robotically with excellent outcomes 5.

Post-Myectomy Persistent Symptoms

If a patient has undergone septal myectomy without MB evaluation and continues to have exertional angina:

• Re-evaluate specifically for MB with provocative angiography 5
• Consider robotic totally endoscopic off-pump unroofing as a standalone procedure 5
• This approach has demonstrated complete symptom relief and return to full activity 5

Common Pitfalls to Avoid

1. Failing to evaluate for MB pre-operatively in HOCM patients scheduled for myectomy—this leads to incomplete treatment and persistent symptoms 5
2. Underestimating MB significance based on resting angiography alone—provocative testing is essential 5
3. Choosing alcohol septal ablation when significant MB is present—this precludes surgical correction of the bridge 1
4. Using vasodilators in an attempt to improve coronary flow—these worsen LVOT obstruction and symptoms 1

Special Populations

In children with HOCM, MB prevalence is 21.4%, and the complexity of disease often includes biventricular obstruction (18.8%) and intraventricular anatomic abnormalities (52.1%) 3. Despite this complexity, surgical outcomes remain favorable with 96.5% survival at 3 years when MB and other abnormalities are addressed comprehensively 3.

Referral to comprehensive HCM centers (Tables 4 and 5 in guidelines) is particularly important when MB is present, as these centers have demonstrated excellence in complex surgical procedures combining myectomy with MB unroofing 8, 1.